Published in J Lipid Res on February 01, 1989
Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. Arterioscler Thromb Vasc Biol (2008) 1.00
Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids (2015) 0.95
Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland. Exp Eye Res (2009) 0.84
Conformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopy. Protein Sci (1997) 0.80
The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice. PLoS One (2012) 0.79
Effect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman Primates. J Biomed Biotechnol (2004) 0.77
Structural studies of a baboon (Papio sp.) plasma protein inhibitor of cholesteryl ester transferase. Protein Sci (2000) 0.75
Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem (1982) 9.77
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med (2001) 7.69
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med (1990) 6.43
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res (1978) 4.84
Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med (1988) 2.65
Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol (2001) 2.42
Caffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial. Am J Clin Nutr (1991) 2.18
Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation (1993) 2.11
Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem (1995) 1.80
A partial cDNA clone for human apolipoprotein B. Proc Natl Acad Sci U S A (1985) 1.76
The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J Clin Invest (1977) 1.75
Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA (1995) 1.74
Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis (1984) 1.73
Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem (1984) 1.70
Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle-aged men. Metabolism (1983) 1.69
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc Natl Acad Sci U S A (1991) 1.69
Heparin--Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem (1978) 1.67
Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem (1978) 1.63
Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet (1991) 1.56
Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism (1976) 1.55
Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem (1994) 1.53
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem (2000) 1.52
Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study. JAMA (1997) 1.50
Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J Lipid Res (1982) 1.48
Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res (1983) 1.46
Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. Clin Chem (1979) 1.43
Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res (1996) 1.42
Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res (1988) 1.41
The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem (1981) 1.36
Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem (1996) 1.30
Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect Immun (2000) 1.29
Lp(a) lipoprotein: relationship to sinking pre-beta lipoprotein hyperlipoproteinemia, and apolipoprotein B. Metabolism (1975) 1.27
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest (1980) 1.25
Coffee intake and elevated cholesterol and apolipoprotein B levels in men. JAMA (1985) 1.22
HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Pathol (1982) 1.21
Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res (1991) 1.21
Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. Metabolism (1985) 1.20
Immunoassay of human plasma apolipoprotein B. Metabolism (1975) 1.19
Receptor-dependent uptake of human chylomicron remnants by cultured skin fibroblasts. J Biol Chem (1981) 1.19
Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J Biol Chem (1995) 1.18
Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. J Clin Invest (1979) 1.18
Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis (1984) 1.17
Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids (1974) 1.17
Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res (1977) 1.16
A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. J Clin Invest (1991) 1.16
Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J). J Lipid Res (2000) 1.16
Distribution and localization of lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity in A-I-containing lipoproteins. J Lipid Res (1986) 1.15
Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res (1982) 1.15
Genetic studies of human apolipoproteins. IX. Apolipoprotein D polymorphism and its relation to serum lipoprotein lipid levels. Am J Hum Genet (1989) 1.12
Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet (1984) 1.12
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology (1985) 1.11
Association of isoapolipoprotein-E3 deficiency with heterozygous familial hypercholesterolaemia: implications for lipoprotein physiology. Lancet (1981) 1.11
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors. Proc Natl Acad Sci U S A (1980) 1.11
Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem (1996) 1.10
Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study. Arterioscler Thromb (1993) 1.09
Radioimmunoassay of human plasma lecithin-cholesterol acyltransferase. J Clin Invest (1981) 1.09
Effect of postpartum lactation on lipoprotein lipids and apoproteins. J Clin Endocrinol Metab (1985) 1.09
Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. J Clin Invest (1979) 1.08
Precipitation methods for quantification of lipoproteins. Methods Enzymol (1986) 1.08
Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Biochemistry (1997) 1.07
Plasma high-density lipoprotein concentrations in chronic-hemodialysis and renal-transplant patients. N Engl J Med (1977) 1.07
Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim Biophys Acta (1996) 1.06
Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. J Clin Invest (1983) 1.06
Associations of diet and alcohol intake with high-density lipoprotein subclasses. Metabolism (1985) 1.06
Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism. Lancet (1977) 1.05
Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab (1979) 1.05
Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem (1999) 1.04
Molecular genetics of apolipoproteins and coronary heart disease. Cold Spring Harb Symp Quant Biol (1986) 1.03
The inheritance of high density lipoprotein cholesterol and apolipoproteins A-I and A-II. Atherosclerosis (1984) 1.03
Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta (1999) 1.03
Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin Chem (1979) 1.03
Uptake of Lp (a) lipoprotein by cultured fibroblasts. Biochem Biophys Res Commun (1981) 1.02
Distribution of lipoproteins and apolipoproteins in young adults The CARDIA Study. Arteriosclerosis (1989) 1.02
Characterization and immunoassay of apolipoprotein D. Atherosclerosis (1981) 1.02
Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and the particle-size distribution of high-density lipoproteins in men. Metabolism (1992) 1.02
National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology (1982) 1.02
Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis. J Clin Invest (1993) 1.02
Identification and genetic control of two rabbit low-density lipoprotein allotypes. Biochem Genet (1968) 1.01
Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease. Annu Rev Med (1993) 1.01
Rapid regulation of the activity of the low density lipoprotein receptor of cultured human fibroblasts. J Biol Chem (1980) 1.01
Apoprotein synthesis by human duodenojejunal mucosa. Gastroenterology (1978) 1.01
Familial apolipoprotein A-I and C-III deficiency, variant II. J Lipid Res (1985) 1.01
Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia. Metabolism (1981) 1.01
Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro. Scand J Clin Lab Invest Suppl (1975) 1.01
Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun (1993) 1.00
A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet (1990) 1.00
Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J Lipid Res (1987) 0.99
Human serum lipoproteins. Evidence for three classes of lipoproteins in S fO-2. Biochemistry (1972) 0.98
Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen. Ann Intern Med (1977) 0.98
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease. Am J Cardiol (1997) 0.98
Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. Clin Chem (1994) 0.97
Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res (1989) 0.97
Isolation, characterization, and assay of lecithin-cholesterol acyltransferase. Methods Enzymol (1986) 0.97
Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase. J Biol Chem (1980) 0.96